120 related articles for article (PubMed ID: 25684034)
1. Management and controversies of classical Hodgkin lymphoma in pregnancy.
Eyre TA; Lau IJ; Mackillop L; Collins GP
Br J Haematol; 2015 Jun; 169(5):613-30. PubMed ID: 25684034
[TBL] [Abstract][Full Text] [Related]
2. The management of hodgkin lymphomas in pregnancies.
Moshe Y; Bentur OS; Lishner M; Avivi I
Eur J Haematol; 2017 Nov; 99(5):385-391. PubMed ID: 28850718
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child.
Sagan D; Semczuk A; Lampka E
J Obstet Gynaecol Res; 2010 Aug; 36(4):882-6. PubMed ID: 20666963
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin lymphoma in pregnancy.
Bachanova V; Connors JM
Curr Hematol Malig Rep; 2013 Sep; 8(3):211-7. PubMed ID: 23749243
[TBL] [Abstract][Full Text] [Related]
5. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
7. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
Pavlovsky S; Corrado C; Pavlovsky MA; Prates MV; Zoppegno L; Giunta M; Cerutti I; Palomino E; Pagani F; Lastiri F; Bar D; Bezares RF; Avila G
Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):181-5. PubMed ID: 20511162
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Tanaka PY; Pessoa VP; Pracchia LF; Buccheri V; Chamone DA; Calore EE
Clin Lymphoma Myeloma; 2007 Mar; 7(5):364-8. PubMed ID: 17562247
[TBL] [Abstract][Full Text] [Related]
10. [Hodgkin's disease in pregnancy--case report and literature review].
Schäffer M; Hegenbart U; Klostermann K; Stepan H
Z Geburtshilfe Neonatol; 2003; 207(2):71-3. PubMed ID: 12740750
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
Ansell SM
Hematol Oncol Clin North Am; 2014 Feb; 28(1):75-86. PubMed ID: 24287069
[TBL] [Abstract][Full Text] [Related]
12. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
Basaran G; Agaoglu F; Basaran M
J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
[No Abstract] [Full Text] [Related]
14. Primary Hodgkin's lymphoma of the rectum: an unusual presentation.
da Costa AA; Flora AC; Stroher M; Soares FA; de Lima VC
J Clin Oncol; 2011 Apr; 29(10):e268-70. PubMed ID: 21220602
[No Abstract] [Full Text] [Related]
15. Treatment of Hodgkin lymphoma: a 50-year perspective.
Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
[No Abstract] [Full Text] [Related]
16. Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.
Rueda A; Olmos D; Viciana R; Alba E
Clin Lymphoma Myeloma; 2006 Mar; 6(5):389-92. PubMed ID: 16640815
[TBL] [Abstract][Full Text] [Related]
17. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy.
Raman V; Quillen K; Sloan JM
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e51-4. PubMed ID: 24342105
[No Abstract] [Full Text] [Related]
18. Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
Borchmann P
Hematol Oncol Clin North Am; 2014 Feb; 28(1):65-74. PubMed ID: 24287068
[TBL] [Abstract][Full Text] [Related]
19. Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire.
Odelia A; Erel J; Chava P; Yair H; Nadav S; Michael L; Irit A
Int J Clin Oncol; 2017 Feb; 22(1):190-199. PubMed ID: 27743147
[TBL] [Abstract][Full Text] [Related]
20. Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
Iannitto E; Minardi V; Gobbi PG; Calvaruso G; Tripodo C; Marcheselli L; Luminari S; Merli F; Baldini L; Stelitano C; Callea V; Petrini M; Angrilli F; Quarta G; Vallisa D; Molica S; Liardo E; Polimeno G; Brugiatelli M; Federico M
Clin Lymphoma Myeloma; 2009 Apr; 9(2):138-44. PubMed ID: 19406724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
